Schettler V - Search Results

1

The German Lipid Apheresis Registry - remaining to be established.

Schettler V, Jaeger BR, Klingel R; German apheresis working group. Schettler V, et al. Atheroscler Suppl. 2009 Dec 29;10(5):59-61. doi: 10.1016/S1567-5688(09)71813-6. Atheroscler Suppl. 2009. PMID: 20129377

2

Lack of plasma lipid peroxidation during LDL-apheresis by heparin-induced extracorporeal LDL-precipitation.

Wieland E, Schettler V, Creutzfeldt C, Kickbusch H, Schuff-Werner P. Wieland E, et al. Among authors: schettler v. Eur J Clin Invest. 1995 Nov;25(11):838-42. doi: 10.1111/j.1365-2362.1995.tb01693.x. Eur J Clin Invest. 1995. PMID: 8582449

3

Highly effective reduction of C-reactive protein in patients with coronary heart disease by extracorporeal low density lipoprotein apheresis.

Wieland E, Schettler V, Armstrong VW. Wieland E, et al. Among authors: schettler v. Atherosclerosis. 2002 May;162(1):187-91. doi: 10.1016/s0021-9150(01)00698-0. Atherosclerosis. 2002. PMID: 11947913

4

First steps toward the establishment of a German low-density lipoprotein-apheresis registry: recommendations for the indication and for quality management.

Schettler V, Wieland E, Armstrong VW, Kleinoeder T, Grunewald RW, Müller GA; Participants of the Göttingen Consensus Conferences. Schettler V, et al. Ther Apher. 2002 Oct;6(5):381-3. doi: 10.1046/j.1526-0968.2002.00426.x. Ther Apher. 2002. PMID: 12423533

5

Impact of chronic LDL-apheresis treatment on Achilles tendon affection in patients with severe familial hypercholesterolemia: a clinical and ultrasonographic 3-year follow-up study.

Scheel AK, Schettler V, Koziolek M, Koelling S, Werner C, Müller GA, Strutz F. Scheel AK, et al. Among authors: schettler v. Atherosclerosis. 2004 May;174(1):133-9. doi: 10.1016/j.atherosclerosis.2004.01.014. Atherosclerosis. 2004. PMID: 15135262

6

Impact of lipid apheresis on Egr-1, c-Jun, c-Fos, and Hsp70 gene expression in white blood cells.

Schettler V, Völker K, Schulz EG, Wieland E. Schettler V, et al. Ther Apher Dial. 2011 Feb;15(1):105-12. doi: 10.1111/j.1744-9987.2010.00861.x. Epub 2010 Sep 26. Ther Apher Dial. 2011. PMID: 21272260

7

Current view: indications for extracorporeal lipid apheresis treatment.

Schettler V, Neumann CL, Hulpke-Wette M, Hagenah GC, Schulz EG, Wieland E; German Apheresis Working Group. Schettler V, et al. Clin Res Cardiol Suppl. 2012 Jun;7(Suppl 1):15-9. doi: 10.1007/s11789-012-0046-6. Clin Res Cardiol Suppl. 2012. PMID: 22528134 Free PMC article.

8

Lipoprotein apheresis--more than just cholesterol reduction?

Neumann CL, Schulz EG, Hagenah GC, Platzer U, Wieland E, Schettler V. Neumann CL, et al. Among authors: schettler v. Atheroscler Suppl. 2013 Jan;14(1):29-32. doi: 10.1016/j.atherosclerosissup.2012.10.017. Atheroscler Suppl. 2013. PMID: 23357137 Review.

9

How to optimize lipoprotein apheresis treatment--a second look.

Schettler V, Neumann CL, Hagenah GC, Schulz EG, Wieland E. Schettler V, et al. Atheroscler Suppl. 2013 Jan;14(1):89-92. doi: 10.1016/j.atherosclerosissup.2012.10.016. Atheroscler Suppl. 2013. PMID: 23357148

10

Lipoprotein Apheresis for Lipoprotein(a)-Associated Cardiovascular Disease: Prospective 5 Years of Follow-Up and Apolipoprotein(a) Characterization.

Roeseler E, Julius U, Heigl F, Spitthoever R, Heutling D, Breitenberger P, Leebmann J, Lehmacher W, Kamstrup PR, Nordestgaard BG, Maerz W, Noureen A, Schmidt K, Kronenberg F, Heibges A, Klingel R; Pro(a)LiFe-Study Group. Roeseler E, et al. Arterioscler Thromb Vasc Biol. 2016 Sep;36(9):2019-27. doi: 10.1161/ATVBAHA.116.307983. Epub 2016 Jul 14. Arterioscler Thromb Vasc Biol. 2016. PMID: 27417585

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

82 results

Search Page

Filters